1. MiR‐200c suppresses TGF‐β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Issue 6 (3rd March 2014) Authors: Bai, Wen‐Dong; Ye, Xing‐Ming; Zhang, Meng‐Yao; Zhu, Hua‐Yu; Xi, Wen‐Jin; Huang, Xun; Zhao, Jiao; Gu, Bin; Zheng, Guo‐Xu; Yang, An‐Gang; Jia, Lin‐Tao Journal: International journal of cancer Issue: Volume 135:Issue 6(2014:Sep. 15) Page Start: 1356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tumor‐suppressive miR‐145 co‐repressed by TCF4‐β‐catenin and PRC2 complexes forms double‐negative regulation loops with its negative regulators in colorectal cancer. Issue 2 (3rd October 2017) Authors: Wang, Wei; Xiao, Xin; Chen, Xu; Huo, Yi; Xi, Wen‐Jin; Lin, Zhi‐Feng; Zhang, Dan; Li, Yu‐Fang; Yang, Fan; Wen, Wei‐Hong; Yang, An‐Gang; Wang, Tao Journal: International journal of cancer Issue: Volume 142:Issue 2(2018) Page Start: 308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗